Increased secretory leukocyte protease inhibitor (SLPI) production by highly metastatic mouse breast cancer cells.
The precise molecular mechanisms enabling cancer cells to metastasize from the primary tumor to different tissue locations are still largely unknown. Secretion of some proteins by metastatic cells could facilitate metastasis formation. The comparison of secreted proteins from cancer cells with diffe...
Saved in:
| Main Authors: | Kevin T Sayers, Alan D Brooks, Thomas J Sayers, Oleg Chertov |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Public Library of Science (PLoS)
2014-01-01
|
| Series: | PLoS ONE |
| Online Access: | https://doi.org/10.1371/journal.pone.0104223 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
SLPI as a dedifferentiation biomarker in BRAFV600E-mutant papillary thyroid cancer
by: Wei Luo, et al.
Published: (2025-08-01) -
Proteases and Protease Inhibitors of Urinary Extracellular Vesicles in Diabetic Nephropathy
by: Luca Musante, et al.
Published: (2015-01-01) -
Therapy of pathology secretory disease of the breast
by: G. Kh. Khanafiev, et al.
Published: (2016-06-01) -
Changes in the activity of lysosomal cysteine proteases of plasma mononuclear and polymorphonuclear blood leukocytes in Alzheimer’s disease
by: M. G. Sorokina, et al.
Published: (2020-10-01) -
A model for transition of 5'-nuclease domain of DNA polymerase I from inert to active modes.
by: Ping Xie, et al.
Published: (2011-01-01)